Pharmaceutical compositions for treatment of EGF receptor associated cancers
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 28, 2001
Grant Date -
N/A
app pub date -
Aug 23, 1999
filing date -
Jul 14, 1995
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention discloses carbohydrates and carbohydrate analogs that bind to epidermal growth factor (EGF) receptors. Methods of using such carbohydrates or analogs for a variety of uses related to the EGF receptor are also provided. In preferred aspects of the present invention, methods for killing or inhibiting the growth of tumor cells with increased EGF receptor activity are disclosed.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully